Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis
暂无分享,去创建一个
David Zurakowski | J. Folkman | D. Zurakowski | C. Butterfield | S. Gillies | K. Moulton | K. Vakili | Judah Folkman | Khashayar Vakili | K. Lo | Kin-Ming Lo | Karen S. Moulton | Mohsin Soliman | Catherine Butterfield | Erik Sylvin | Stephen Gillies | Kashi Javaherian | K. Javaherian | Erik A. Sylvin | Mohsin Q. Soliman | E. Sylvin
[1] Lars Holmgren,et al. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma , 1994, Cell.
[2] Shay Soker,et al. Neuropilin-1 Is Expressed by Endothelial and Tumor Cells as an Isoform-Specific Receptor for Vascular Endothelial Growth Factor , 1998, Cell.
[3] C. Weyand,et al. Formation of new vasa vasorum in vasculitis. Production of angiogenic cytokines by multinucleated giant cells. , 1999, The American journal of pathology.
[4] C. Alpers,et al. Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. , 1996, Circulation.
[5] E. Unanue,et al. Activated macrophages induce vascular proliferation , 1977, Nature.
[6] D. Heistad,et al. Diffusional support of the thoracic aorta in atherosclerotic monkeys. , 1987, Atherosclerosis.
[7] R. Ross,et al. Atherosclerosis is an inflammatory disease. , 1998, American heart journal.
[8] R. Nicosia,et al. Growth of microvessels in serum-free matrix culture of rat aorta. A quantitative assay of angiogenesis in vitro. , 1990, Laboratory investigation; a journal of technical methods and pathology.
[9] M. Moses,et al. HIF-1alpha-mediated up-regulation of vascular endothelial growth factor, independent of basic fibroblast growth factor, is important in the switch to the angiogenic phenotype during early tumorigenesis. , 2001, Cancer research.
[10] D. Heistad,et al. Vasa Vasorum in Atherosclerotic Coronary Arteries: Responses to Vasoactive Stimuli and Regression of Atherosclerosis , 1988, Circulation research.
[11] M A Konerding,et al. Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. , 1999, Circulation.
[12] S M Schwartz,et al. Angiogenesis in human coronary atherosclerotic plaques. , 1994, The American journal of pathology.
[13] Shigeyoshi Itohara,et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis , 2000, Nature Cell Biology.
[14] M. Dake,et al. Vascular endothelial growth factor enhances atherosclerotic plaque progression , 2001, Nature Medicine.
[15] M. Davies,et al. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. , 1993, British heart journal.
[16] O. Wiklund,et al. Evidence of hypoxic areas within the arterial wall in vivo. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[17] A. Luttun,et al. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1 , 2002, Nature Medicine.
[18] A. Barger,et al. Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis. , 1984, The New England journal of medicine.
[19] P. Ridker,et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. , 2000, The New England journal of medicine.
[20] M. Cybulsky,et al. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. , 2001, The Journal of clinical investigation.
[21] D. Hanahan,et al. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. , 1999, Science.
[22] D. Sane,et al. Angiostatin binds to smooth muscle cells in the coronary artery and inhibits smooth muscle cell proliferation and migration In vitro. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[23] R. Nicosia,et al. Endogenous regulation of angiogenesis in the rat aorta model. Role of vascular endothelial growth factor. , 1997, The American journal of pathology.
[24] I. Weissman,et al. Flow cytometric identification of murine neutrophils and monocytes. , 1996, Journal of immunological methods.
[25] E L Ritman,et al. Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolemia. , 1998, The Journal of clinical investigation.
[26] Claudio Napoli,et al. Simvastatin Preserves the Structure of Coronary Adventitial Vasa Vasorum in Experimental Hypercholesterolemia Independent of Lipid Lowering , 2002, Circulation.
[27] P. Libby,et al. Reduction of atherosclerosis in mice by inhibition of CD40 signalling , 1998, Nature.
[28] J. Folkman. Angiogenesis in cancer, vascular, rheumatoid and other disease , 1995, Nature Medicine.
[29] Ho-Jin Park,et al. 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors Interfere With Angiogenesis by Inhibiting the Geranylgeranylation of RhoA , 2002, Circulation research.
[30] A. Mantovani,et al. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. , 1996, Blood.
[31] P. Libby,et al. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. , 1998, Molecular cell.
[32] P. Tsao,et al. Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis , 2001, Nature Medicine.